story of the week
Dose-Dense Temozolomide + Lapatinib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neuro-oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
Neuro-oncology 2020 Oct 21;[EPub Ahead of Print], MR Gilbert, Y Yuan, J Wu, T Mendoza, E Vera, A Omuro, F Lieberman, HI Robins, ER Gerstner, J Wu, PY Wen, T Mikkelsen, K Aldape, TS ArmstrongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.